Innovating Disease Protection for the 21st Century

At Brazen Goods Inc., we’re not just developing products, we're pioneering a new standard for health & safety. Our innovative products address gaps in infectious disease protection, empowering people to enjoy freedom without compromising their health.

Leveraging Science and Fashion for Optimal Protection

Our patented ultra-thin elastomeric garments, known as Lorals, offer unprecedented protection. Designed in collaboration with experts from the medical device and fashion industries, Lorals combine functionality with aesthetic appeal, creating a product that not only provides critical protection but also feels and looks great.

A Global Impact

Our breakthrough products have garnered international attention, with features in the New York Times, Fast Company, US News & World Report, Forbes, Cosmopolitan, Women's Health, and hundreds of other publications worldwide. Customers in over 80 countries trust Lorals for protection and comfort, underlining our worldwide impact on healthcare.

Regulatory Excellence and Legal Commitment

Brazen Goods is proud to be a front-runner in regulatory innovation, obtaining the FDA’s first-ever 510(k)-cleared underwear devices—an achievement highlighted by the New York Times in May 2022. This clearance reflects our dedication to rigorous safety and quality standards. Led by our Columbia Law School-educated founder, we are committed to navigating complex regulatory frameworks to ensure our products meet all necessary approvals and clearances, reinforcing our pledge to consumer safety and legal integrity.

Building Partnerships for a Healthier Future

We understand that solving today's healthcare challenges requires collective action. Brazen Goods is trusted by public health departments, community centers, universities, healthcare providers, and clinics across the U.S. Through these partnerships, Brazen Goods’ products are accessible to approximately 36 million individuals nationwide, making infectious disease protection more accessible to all.